Scholar Rock says apitegromab EU approval delayed by facility review Jul 20, 2026 08:00AM
Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (CHMP) Opinion for Apitegromab Marketing Authorisation Application (MAA) for Spinal Muscular Atrophy (SMA) Jul 20, 2026 08:00AM
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jul 17, 2026 04:15PM
Scholar Rock to Report Second Quarter 2026 Financial Results on August 6, 2026 Jul 16, 2026 08:00AM
Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD Jun 22, 2026 08:00AM
View Older Stories

Jun 12, 2026 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 26, 2026 09:30AM Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 20, 2026 08:00AM Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference
May 15, 2026 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 7, 2026 07:00AM Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights
Apr 29, 2026 08:00AM Scholar Rock to Present at the BofA Securities 2026 Health Care Conference
Apr 17, 2026 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 16, 2026 08:00AM Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026
Mar 31, 2026 07:01AM Scholar Rock resubmits drug application to FDA for SMA treatment
Mar 31, 2026 07:00AM Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
Mar 13, 2026 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 3, 2026 07:00AM Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Mar 3, 2026 07:00AM CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Feb 18, 2026 08:00AM Scholar Rock to Present at Upcoming Investor Conferences
Feb 13, 2026 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 10, 2026 08:00AM Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
Jan 16, 2026 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 12, 2026 07:05AM Scholar Rock targets 2026 apitegromab BLA resubmission and launch
Jan 12, 2026 07:00AM Scholar Rock Highlights 2026 Strategic Priorities
Jan 5, 2026 08:00AM Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference
Dec 13, 2025 10:57AM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 18, 2025 08:00AM Scholar Rock to Present at Upcoming Investor Conferences
Nov 14, 2025 07:00AM Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Nov 12, 2025 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 4, 2025 08:00AM Scholar Rock to Present at the 2025 Jefferies Global Healthcare Conference
Oct 23, 2025 08:00AM Scholar Rock to Report Third Quarter 2025 Financial Results on November 14, 2025
Oct 17, 2025 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 23, 2025 07:00AM FDA rejects Scholar Rock's apitegromab application due to facility issues
Sep 23, 2025 07:00AM FDA Issues Complete Response Letter (CRL) for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Solely Related to Observations Identified at Catalent Indiana LLC Fill-Finish F
Sep 12, 2025 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 15, 2025 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 14, 2025 08:00AM Pivotal SAPPHIRE Trial Data Published in The Lancet Neurology: Apitegromab Demonstrated Significant Motor Function Gains for Children and Adults with SMA on SMN-Targeted Treatment
Aug 6, 2025 07:00AM Scholar Rock Reports Second Quarter 2025 Financial Results and Highlights Business Progress
Jul 21, 2025 08:00AM Scholar Rock to Host Conference Call to Discuss Second Quarter 2025 Financial Results and Provide Business Update on August 6, 2025
Jul 18, 2025 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 23, 2025 08:00AM Scholar Rock to Present Comprehensive Update at 2025 Annual Cure SMA Research and Clinical Care Meeting, Including Positive Results from Pivotal Phase 3 SAPPHIRE Trial
Jun 18, 2025 07:00AM Scholar Rock Holding (SRRK) Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss
Jun 18, 2025 07:00AM Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss
Jun 13, 2025 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 5, 2025 08:00AM Scholar Rock to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
Jun 2, 2025 08:05AM Scholar Rock Holding Corp. (SRRK) Appoints as Rebecca McLeod Chief Brand Officer and U.S. General Manager
Jun 2, 2025 08:00AM Scholar Rock Appoints Rebecca McLeod Chief Brand Officer and U.S. General Manager
May 28, 2025 08:00AM Scholar Rock to Present at the Jefferies Global Healthcare Conference
May 16, 2025 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 14, 2025 07:00AM Scholar Rock Reports First Quarter 2025 Financial Results and Highlights Business Progress
May 7, 2025 08:00AM Scholar Rock to Host Conference Call to Discuss First Quarter 2025 Financial Results and Provide Business Update on May 14, 2025
May 6, 2025 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 28, 2025 07:03AM Scholar Rock Holding Corp. (SRRK) Appoints David L. Hallal as CEO
Apr 28, 2025 06:50AM Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth
Apr 18, 2025 04:15PM Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View Older Stories